| Primary |
| Diabetes Mellitus |
31.9% |
| Type 2 Diabetes Mellitus |
28.5% |
| Hypertension |
13.6% |
| Constipation |
3.8% |
| Nephrotic Syndrome |
3.0% |
| Angina Pectoris |
2.8% |
| Hypercholesterolaemia |
1.8% |
| Gastritis |
1.4% |
| Rheumatoid Arthritis |
1.4% |
| Type 1 Diabetes Mellitus |
1.4% |
| Arteriosclerosis |
1.2% |
| Blood Pressure Management |
1.2% |
| Gastritis Prophylaxis |
1.2% |
| Pulmonary Tuberculosis |
1.2% |
| Hyperlipidaemia |
1.0% |
| Percutaneous Coronary Intervention |
1.0% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.0% |
| Urethritis |
1.0% |
| Atrial Fibrillation |
0.8% |
| Cerebrovascular Accident Prophylaxis |
0.8% |
|
| Hepatic Function Abnormal |
17.5% |
| Hypoglycaemia |
14.5% |
| Liver Disorder |
13.9% |
| Pneumatosis Intestinalis |
9.0% |
| Liver Function Test Abnormal |
6.0% |
| Ileus |
5.4% |
| Intestinal Ischaemia |
3.6% |
| Subileus |
3.6% |
| Diarrhoea |
3.0% |
| Hepatitis |
3.0% |
| Transaminases Increased |
3.0% |
| Alanine Aminotransferase Increased |
2.4% |
| Malaise |
2.4% |
| Chest Discomfort |
1.8% |
| Constipation |
1.8% |
| Drug-induced Liver Injury |
1.8% |
| Fall |
1.8% |
| Gastric Cancer |
1.8% |
| Hepatic Enzyme Increased |
1.8% |
| Intestinal Obstruction |
1.8% |
|
| Secondary |
| Hypertension |
24.7% |
| Type 2 Diabetes Mellitus |
20.7% |
| Diabetes Mellitus |
17.2% |
| Angina Pectoris |
4.7% |
| Cardiovascular Disorder |
4.0% |
| Hypercholesterolaemia |
3.0% |
| Rash |
2.8% |
| Drug Use For Unknown Indication |
2.6% |
| Lacunar Infarction |
2.3% |
| Gastritis Prophylaxis |
2.1% |
| Product Used For Unknown Indication |
2.1% |
| Gastritis |
1.9% |
| Osteoarthritis |
1.9% |
| Percutaneous Coronary Intervention |
1.9% |
| Cough |
1.6% |
| Cholelithiasis |
1.4% |
| Depression |
1.4% |
| Insomnia |
1.4% |
| Anxiety Disorder |
1.2% |
| Cerebral Infarction |
1.2% |
|
| Liver Disorder |
19.3% |
| Prostate Cancer |
12.0% |
| Hypoglycaemia |
10.8% |
| Liver Function Test Abnormal |
8.4% |
| Convulsion |
4.8% |
| Hepatic Function Abnormal |
4.8% |
| Colonic Polyp |
3.6% |
| Diarrhoea |
3.6% |
| Drug Exposure During Pregnancy |
3.6% |
| Thrombocytopenia |
3.6% |
| Ventricular Extrasystoles |
3.6% |
| Alanine Aminotransferase Increased |
2.4% |
| Drug-induced Liver Injury |
2.4% |
| In-stent Coronary Artery Restenosis |
2.4% |
| Intentional Overdose |
2.4% |
| Intestinal Obstruction |
2.4% |
| Myocardial Ischaemia |
2.4% |
| Pruritus Generalised |
2.4% |
| Rhabdomyolysis |
2.4% |
| Tumour Marker Increased |
2.4% |
|
| Concomitant |
| Diabetes Mellitus |
21.4% |
| Hypertension |
20.6% |
| Type 2 Diabetes Mellitus |
9.7% |
| Product Used For Unknown Indication |
6.8% |
| Prophylaxis |
5.9% |
| Rheumatoid Arthritis |
4.9% |
| Drug Use For Unknown Indication |
4.4% |
| Hepatitis C |
3.7% |
| Hyperlipidaemia |
3.2% |
| Gastritis |
2.5% |
| Cardiac Failure |
2.3% |
| Atrial Fibrillation |
2.2% |
| Osteoporosis |
1.9% |
| Metastatic Renal Cell Carcinoma |
1.8% |
| Constipation |
1.8% |
| Hyperuricaemia |
1.8% |
| Insomnia |
1.5% |
| Renal Transplant |
1.4% |
| Multiple Myeloma |
1.2% |
| Thrombosis Prophylaxis |
1.2% |
|
| Hypoglycaemia |
11.9% |
| Renal Impairment |
9.1% |
| Liver Disorder |
7.7% |
| Hepatic Function Abnormal |
7.0% |
| White Blood Cell Count Decreased |
6.3% |
| Anaemia |
5.6% |
| Interstitial Lung Disease |
5.6% |
| Platelet Count Decreased |
4.9% |
| Rash |
4.9% |
| Lacunar Infarction |
4.2% |
| Umbilical Cord Around Neck |
4.2% |
| Diabetic Ketoacidosis |
3.5% |
| Gastrointestinal Haemorrhage |
3.5% |
| Nasopharyngitis |
3.5% |
| Prostatic Specific Antigen Increased |
3.5% |
| Renal Failure |
3.5% |
| Angina Pectoris |
2.8% |
| Calculus Urinary |
2.8% |
| Condition Aggravated |
2.8% |
| Decreased Appetite |
2.8% |
|
| Interacting |
| Computerised Tomogram |
100.0% |
|
|
